Doxifluridine combined with weekly paclitaxel for second-line treatment in patients with gastric cancer resistant to TS-1
暂无分享,去创建一个
K. Kurashina | Kazuya Sakuma | H. Nagai | Y. Hosoya | W. Arai | Y. Yasuda | H. Haruta | M. Hyodo | T. Zuiki | T. Yokoyama | Shin Saito | Y. Hirashima